Accorto Announces Addition of Dr. Kevin Lye as Medical Advisor
RICHMOND, VIRGINIA - NOV. 24, 2023 At Accorto, we strive [...]
Use Of International Standard ISO 10993-1, “Biological Evaluation Of Medical Devices – Part 1: Evaluation And Testing Within A Risk Management Process” GalleryUse Of International Standard ISO 10993-1, “Biological Evaluation Of Medical Devices – Part 1: Evaluation And Testing Within A Risk Management Process”
Use Of International Standard ISO 10993-1, “Biological Evaluation Of Medical Devices – Part 1: Evaluation And Testing Within A Risk Management Process”
FDA has developed this guidance document to assist industry in [...]
CDRH Statement: FDA Continues To Take Steps To Strengthen The Premarket Notification [510(K)] Program
Today, the U.S. Food and Drug Administration issued three new [...]
What MoCRA Means for the US Cosmetics Industry
On December 29, 2022, the Modernization of Cosmetics Regulation [...]
FDA Proposes New Requirements for Tobacco Product Manufacturing Practices
Today, the U.S. Food and Drug Administration is proposing new [...]
FDA Denies Marketing of 250+ Flavored and Tobacco-Flavored E-Liquids
Today, FDA issued marketing denial orders to the firm Mothers [...]
FDA Conducts Retailer Inspection Blitz, Cracks Down on Illegal Sales of Popular Disposable E-cigarettes
Today, the U.S. Food and Drug Administration issued warning letters to 30 [...]
FDA and NIH Award Funding for New Center for Rapid Surveillance of Tobacco
FDA and the National Institutes of Health (NIH) have awarded [...]
FDA Announces Additional Steps to Modernize Clinical Trials
Today, the U.S. Food and Drug Administration is announcing the [...]
FDA Concludes that Existing Regulatory Frameworks for Foods and Supplements are Not Appropriate for Cannabidiol, Will Work with Congress on a New Way Forward GalleryFDA Concludes that Existing Regulatory Frameworks for Foods and Supplements are Not Appropriate for Cannabidiol, Will Work with Congress on a New Way Forward
FDA Concludes that Existing Regulatory Frameworks for Foods and Supplements are Not Appropriate for Cannabidiol, Will Work with Congress on a New Way Forward
FDA Concludes that Existing Regulatory Frameworks for Foods and [...]
